Smith & Nephew plc
Research Smith & Nephew plc (SNN) on Bullrun: market cap USD 12.88B, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSNN
- ExchangeNYSE
- CountryUnited Kingdom
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Market capUSD 12.88B
- Dividend yield2.6%
- Financial periodFY2025
- RevenueUSD 6.16B
- Revenue growth6.1%
- Net incomeUSD 625.00M
- Free cash flowUSD 852.00M
- Gross margin68.0%
Valuation Snapshot
latest market cap is USD 12.88B; dividend yield is 2.6%.
About Smith & Nephew plc
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. It offers knee implant products for knee replacement procedures; hip implants for revision procedures;
Frequently asked questions
What is Smith & Nephew plc's market cap?
Smith & Nephew plc's market capitalization is USD 12.88B.
Does Smith & Nephew plc pay a dividend?
Smith & Nephew plc has a dividend yield of 2.6%.
What does Smith & Nephew plc do?
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. The company operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.